Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Succinate dehydrogenase complex assembly factor 2 (SDHAF2) is a mitochondrial protein essential for the assembly and functional maturation of complex II (succinate dehydrogenase) in the respiratory chain. SDHAF2 mediates the covalent incorporation of the cofactor flavin adenine dinucleotide (FAD) into the SDHA subunit, a critical step for the enzyme’s catalytic activity[1][2][3][4]. SDHAF2 acts as a tumor suppressor: loss-of-function mutations lead to impaired succinate dehydrogenase activity, succinate accumulation, and abnormal stabilization of hypoxia-inducible factor (HIF), promoting tumorigenesis, particularly hereditary paraganglioma and pheochromocytoma syndrome[1][3][4]. The gene is located on chromosome 11q12.2 and encodes a small, highly conserved protein consisting of 65 amino acids, organized as a five-helix bundle that interacts directly with complex II subunits to ensure proper enzyme assembly and function[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Succinate dehydrogenase complex assembly factor 2 (SDHAF2).